A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF ORALLY ADMINISTERED SP-303 FOR THE TREATMENT OF DIARRHEA IN ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) PATIENTS: